vTv Therapeutics (VTVT) Notes Payables: 2014-2025
Historic Notes Payables for vTv Therapeutics (VTVT) over the last 4 years, with Sep 2025 value amounting to $328,000.
- vTv Therapeutics' Notes Payables was N/A to $328,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $328,000, marking a year-over-year change of. This contributed to the annual value of $191,000 for FY2023, which is 14.73% down from last year.
- According to the latest figures from Q3 2025, vTv Therapeutics' Notes Payables is $328,000, which was up 71.73% from $191,000 recorded in Q4 2023.
- In the past 5 years, vTv Therapeutics' Notes Payables ranged from a high of $636,000 in Q3 2021 and a low of $191,000 during Q4 2023.
- Its 2-year average for Notes Payables is $330,667, with a median of $328,000 in 2025.
- Over the last 5 years, vTv Therapeutics' Notes Payables had its largest YoY gain of 204.76% in 2021, and its largest YoY loss of 73.15% in 2021.
- vTv Therapeutics' Notes Payables (Quarterly) stood at $256,000 in 2021, then fell by 12.50% to $224,000 in 2022, then dropped by 14.73% to $191,000 in 2023, then reached $328,000 in 2025.
- Its Notes Payables was $328,000 in Q3 2025, compared to $191,000 in Q4 2023 and $473,000 in Q3 2023.